Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerative, Date of authorisation: 22/01/2007, Revision: 43, Status: Authorised

Submitted by Anonymous (not verified) on 9 October 2023 - 11:55

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerative, Date of authorisation: 22/01/2007, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Anovulation;Reproductive Techniques, Assisted;Infertility, Female;Hypogonadism, Date of authorisation: 20/10/1995, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 9 October 2023 - 11:23

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Anovulation;Reproductive Techniques, Assisted;Infertility, Female;Hypogonadism, Date of authorisation: 20/10/1995, Revision: 26, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More